D.A. Davidson & Co’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$357K Sell
25,750
-60,300
-70% -$961K ﹤0.01% 1293
2025
Q4
$1.4M Sell
86,050
-150
-0.2% -$2.45K 0.01% 784
2025
Q3
$1.29M Sell
86,200
-4,400
-5% -$53.6K 0.01% 784
2025
Q2
$1.06M Sell
90,600
-1,250
-1% -$11.4K 0.01% 799
2025
Q1
$682K Buy
91,850
+3,400
+4% +$26.1K 0.01% 905
2024
Q4
$530K Buy
88,450
+6,725
+8% +$37.1K ﹤0.01% 989
2024
Q3
$418K Sell
81,725
-4,500
-5% -$19.6K ﹤0.01% 1082
2024
Q2
$312K Buy
86,225
+28,100
+48% +$89.2K ﹤0.01% 1148
2024
Q1
$187K Buy
58,125
+11,150
+24% +$43.1K ﹤0.01% 1298
2023
Q4
$230K Sell
46,975
-6,900
-13% -$31.5K ﹤0.01% 1200
2023
Q3
$294K Sell
53,875
-29,400
-35% -$194K ﹤0.01% 1093
2023
Q2
$559K Buy
83,275
+29,550
+55% +$220K 0.01% 891
2023
Q1
$474K Buy
53,725
+15,325
+40% +$135K 0.01% 909
2022
Q4
$293K Sell
38,400
-3,150
-8% -$24.5K ﹤0.01% 1052
2022
Q3
$296K Buy
41,550
+1,385
+3% +$13K ﹤0.01% 1008
2022
Q2
$325K Buy
40,165
+15,370
+62% +$135K ﹤0.01% 975
2022
Q1
$344K Buy
24,795
+6,850
+38% +$108K ﹤0.01% 1019
2021
Q4
$504K Buy
17,945
+1,160
+7% +$35.6K 0.01% 874
2021
Q3
$571K Buy
16,785
+875
+5% +$31.6K 0.01% 794
2021
Q2
$650K Buy
15,910
+525
+3% +$20.4K 0.01% 756
2021
Q1
$619K Buy
15,385
+4,750
+45% +$257K 0.01% 735
2020
Q4
$629K Sell
10,635
-100
-0.9% -$5.16K 0.01% 629
2020
Q3
$522K Sell
10,735
-280
-3% -$11.8K 0.01% 601
2020
Q2
$533K Sell
11,015
-5,375
-33% -$196K 0.01% 576
2020
Q1
$455K Buy
16,390
+3,120
+24% +$87K 0.01% 615
2019
Q4
$397K Buy
+13,270
New +$381K 0.01% 737

Other funds holding ADPT